Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:07 PM ET 10-Q
Financial Results First Hawaiian, Inc. FHB

First Hawaiian Q3 2026 Results: Net Income $63.7M, Down 13.7% YoY

First Hawaiian, Inc. reported net income of $63.7 million for the third quarter of 2026, a decrease from $73.8 million in the prior year period, primarily driven by a significant increase in the provision for credit losses and higher noninterest expenses. Despite lower net income, the company maintained a strong capital position with total stockholders' equity of $2.8 billion and declared cash dividends of $0.26 per share for the quarter.

Key figure
Net income $63.7M · -13.7% YoY
4:07 PM ET Form 4
Insider Buying Bambusa Therapeutics, Inc. BBTX

Bambusa Therapeutics 10% Owner Investment GmbH Salvia Buys $6M of Stock

Investment GmbH Salvia, 10% Owner, bought 375,000 shares of Bambusa Therapeutics, Inc. at $16.00 a share, worth $6M in total on Nov 2, 2026. Shares held after the trade: 9,264,301 (+4.2%).

Value
$6M
Shares
375,000
Price
$16.00
Role
10% Owner
Holding change
+4.2%
Trade date
Nov 2, 2026
4:07 PM ET Form 4
Insider Selling Waste Connections, Inc. WCN

Waste Connections Sr VP Chief Tax Officer Matthew Stephen Black Sells $1.99M of Stock

Matthew Stephen Black, Sr VP Chief Tax Officer, sold 11,000 shares of Waste Connections, Inc. at $180.04 to $181.15 a share (average $180.60) in 2 transactions, worth $1.99M in total on Oct 29, 2026. Shares held after the trade: 32,530 (-14.3%).

Value
$1.99M
Shares
11,000
Average price
$180.60
Role
Sr VP Chief Tax Officer
Holding change
-14.3%
Trade date
Oct 29, 2026
4:07 PM ET 8-K
Financial Results Biomarin Pharmaceutical Inc BMRN

Biomarin Pharmaceutical Financial Results

BioMarin reported third-quarter 2026 financial results, achieving a milestone of over $1 billion in quarterly revenue, a 32% year-over-year increase. Growth was driven by the acquisition of Amicus Therapeutics and strong demand for metabolic and skeletal condition treatments. The company also announced an FDA PDUFA date of May 30, 2027, for the potential expansion of VOXZOGO into hypochondroplasia.

Term
Q3 2026

“BioMarin delivered a strong quarter, with revenue growth of 32%, driven by a more diversified portfolio following the acquisition of Amicus Therapeutics earlier this year and increased demand for our medicines from patients around the world. For the first time, quarterly revenue exceeded $1 billion, a milestone for BioMarin.”

Alexander Hardy, President and Chief Executive Officer

“As we approach 2027, we are well positioned for our next chapter of growth, including the potential launch of VOXZOGO in hypochondroplasia and the continued execution of our financial and innovation strategy.”

Alexander Hardy, President and Chief Executive Officer
4:07 PM ET 10-Q
Financial Results Onex Direct Lending BDC Fund

Onex Direct Lending BDC Fund Q3 2026 Results: Turns Profitable, Net Income $2.02M

Onex Direct Lending BDC Fund reported a net decrease in net assets resulting from operations of $19.1 million for the nine months ended September 30, 2026, primarily driven by $56.0 million in net realized losses. The fund's Net Asset Value (NAV) per share declined from $20.81 at the end of 2025 to $17.04 as of September 30, 2026, amid elevated shareholder repurchase requests.

Key figure
Net income $2.02M
4:07 PM ET 8-K
Financial Results Williams Companies, Inc. WMB

Williams Companies Financial Results

Williams reported strong third-quarter 2026 results with GAAP net income of $699 million and Adjusted EBITDA of $2.039 billion, up 6% year-over-year. The company closed its acquisition of Momentum Midstream and is tracking toward the upper half of its full-year 2026 Adjusted EBITDA guidance range of $8.3 billion to $8.5 billion.

Term
Q3 2026

“Williams delivered another strong quarter as our teams continued to execute across a growing portfolio of critical energy infrastructure projects. Year-to-date Adjusted EBITDA increased 9% year over year to $6.2 billion, reflecting the strength of our natural gas transmission, storage and gathering businesses and keeping us on track toward the upper half of our 2026 guidance range. Our performance to date, combined with a growing slate of projects set to come online, gives us strong confidence in our ability to achieve our long-term 11% plus Adjusted EBITDA compound annual growth rate through 2030.”

Chad Zamarin, president and chief executive officer

“I am especially proud of our team's exceptional execution to bring Socrates fully online ahead of schedule. As the first of many power projects, Socrates demonstrates our ability to deliver fast, reliable and scalable solutions for customers facing rapidly growing power demand, and we are actively working to commercialize additional power projects, which we expect to announce soon. We also closed the Momentum Midstream acquisition ahead of schedule, enhancing our premier footprint in the Haynesville — America’s fastest-growing natural gas basin — which strengthens Williams' ability to serve growing LNG, power and industrial demand. Across our broader portfolio, we announced new Transco projects and expansions, advanced a storage expansion at Clay Basin, and placed four pipeline projects into service.”

Chad Zamarin, president and chief executive officer
4:07 PM ET 8-K
Financial Results Diamondback Energy, Inc. FANG

Diamondback Energy Financial Results

Diamondback Energy reported Q3 2026 financial results with average oil production of 525 MBO/d and net cash from operating activities of $2.6 billion. The company increased its annual base dividend by 7.3% to $4.72 per share and raised its full-year 2026 production guidance.

Term
Q3 2026
4:07 PM ET 8-K
Financial Results Palantir Technologies Inc. PLTR

Palantir Technologies Financial Results

Palantir reported record Q3 2026 results with total revenue growing 96% year-over-year to $2.31 billion, driven by a 148% surge in U.S. commercial revenue. For the first time in company history, U.S. commercial revenue ($984 million) surpassed U.S. government revenue ($953 million).

Term
Q3 2026

“The Sovereign AI movement is imposing the most dramatic dichotomy between haves and have nots that I have witnessed in 30 years of business. Every institution—government and commercial—is rapidly being forced, voluntarily or not, into one of these two categories.”

Alex Karp, Co-Founder and Chief Executive Officer of Palantir Technologies

“Witness our third quarter results: overall revenue soared 96% year-over-year, U.S. commercial revenue grew 148% year-over-year and 29% sequentially, and aggregate U.S. revenue grew 119% year-over-year. Our U.S. commercial revenue has surpassed our U.S. government revenue for the first time in our company’s history.”

Alex Karp, Co-Founder and Chief Executive Officer of Palantir Technologies
4:07 PM ET 8-K
Financial Results Vitesse Energy, Inc. VTS

Vitesse Energy Financial Results

Vitesse Energy reported Q3 2026 financial results, including production of 16,824 Boe per day and Adjusted EBITDA of $39.3 million. The quarter was highlighted by the closing of a DJ Basin acquisition and the declaration of a $0.4375 per share quarterly dividend.

Term
Q3 2026

“The third quarter was highlighted by the successful closing of the DJ Basin acquisition, which reinforces our ability to identify and capitalize on attractive investment opportunities. We expect the transaction to add meaningful cash flow at a valuation accretive to all key metrics while expanding our position in the DJ Basin. This investment, along with anticipated continuation of accelerated drilling and completion activities, reflects Vitesse’s strategy of disciplined capital allocation, strengthening our portfolio, supporting our dividend, and generating sustainable returns for our stockholders.”

Jamie Benard, Vitesse’s President and Chief Executive Officer

“Vitesse’s balance sheet remains conservative, with target leverage at or below 1.0x. Our hedge portfolio is designed to provide additional cash flow visibility and supports our confidence in maintaining our quarterly dividend and low leverage.”

James Henderson, Vitesse’s Chief Financial Officer
4:07 PM ET 8-K
Financial Results V2X, Inc. VVX

V2X Financial Results

V2X, Inc. reported third quarter 2026 revenue of $1.27 billion, a 9% increase year-over-year, driven by strong demand for mission-critical capabilities. The company increased its full-year 2026 guidance across all key metrics, including revenue and adjusted EBITDA, citing a robust backlog of $12.8 billion.

Term
Q3 2026

“We delivered another strong quarter, with revenue growth and double-digit increases in net income and diluted EPS. Our results reflect our team’s consistent execution and continued demand for V2X’s mission-critical capabilities.”

Jeremy C. Wensinger, President and Chief Executive Officer

“Based on our year-to-date performance, current backlog position and existing demand signals, we are increasing our full-year 2026 guidance. Looking forward, we expect to continue investing in areas of growth that we believe will enable us to advance our Go Towards Tomorrow strategy, create long-term value for our shareholders and deliver for our customers and their missions.”

Jeremy C. Wensinger, President and Chief Executive Officer
4:07 PM ET 10-Q
Financial Results V2X, Inc. VVX

V2X Q3 2026 Results: Net Income $32M, Up 30.0% YoY

V2X, Inc. reported strong growth for the third quarter of 2026, with revenue increasing to $1.27 billion compared to $1.17 billion in the prior year period. Net income for the nine months ended October 2, 2026, rose significantly to $76.5 million, up from $55.1 million in 2025, driven by higher operating income and reduced interest expenses.

Key figure
Net income $32M · +30.0% YoY
4:07 PM ET 8-K
Financial Results Hinge Health, Inc. HNGE

Hinge Health Financial Results

Hinge Health reported record Q3 2026 results with revenue growing 52% year-over-year to $235 million and a significant increase in non-GAAP operating margin to 33%. The company raised its full-year 2026 revenue guidance to approximately $880 million and announced that President James Pursley will transition to a role on the Board of Directors in January 2027.

Term
Q3 2026

“Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale. This focus on the triple aim, via a technology platform that scales and automates care delivery, is also resulting in a record sales season.”

Daniel Perez, Co-Founder and CEO

“We wouldn't be the company we are today if not for Jim. He's been instrumental in our scaling to over 3,200 clients. I'm grateful for all he's done and that he'll continue contributing to our success as a board member and advisor.”

Daniel Perez, Co-Founder and CEO
4:07 PM ET 8-K
Loan & Debt Workhorse Group Inc. WKHS

Workhorse Group $30M Debt Financing with Motive GM Holdings II LLC

Workhorse Group entered into amendments to its existing credit agreements with Motive GM Holdings II LLC to increase the commitment under the Customer Order Credit Agreement from $20 million to $30 million. The amendments also defer interest payments on several recent $10 million loan tranches until after March 31, 2027, providing the company with additional liquidity and near-term cash flow relief.

Value
$30M
Counterparty
Motive GM Holdings II LLC
4:07 PM ET 8-K
Leadership Change Pool Corp POOL

Pool Leadership Change

John E. Stokely has transitioned from interim Executive Chair back to Lead Independent Director after the Board determined he qualifies as independent under Nasdaq standards. Consequently, David G. Whalen ceased serving as lead independent director, and the additional fees associated with these interim leadership roles have been terminated.

4:07 PM ET 10-Q
Financial Results Sabra Health Care REIT, Inc. SBRA ▶ Call

Sabra Health Care REIT Q3 2026 Results: Net Income $28.6M, Up 26.9% YoY

Sabra Health Care REIT reported total revenues of $707.2 million for the nine months ended September 30, 2026, compared to $562.7 million in the prior year period. Net income attributable to Sabra decreased to $44.1 million from $128.4 million year-over-year, primarily driven by a $104.6 million provision for loan losses and other reserves.

Key figure
Net income $28.6M · +26.9% YoY
4:07 PM ET 8-K
Investor Presentation Franklin Financial Services Corp FRAF

Franklin Financial Services Investor Presentation

Franklin Financial Services Corporation filed a formal investor presentation dated November 2, 2026, to be used by executives in meetings with investors and analysts. The presentation provides strategic highlights and operational updates for the bank holding company and its subsidiary, Farmers and Merchants Trust Company.

4:07 PM ET 8-K
Loan & Debt Diversified Energy Co DEC

Diversified Energy $1B Debt Financing with Truist Bank

Diversified Energy's subsidiary entered into a fourth amendment to its revolving credit agreement, increasing the borrowing base and elected commitments from $900 million to $1 billion. The amendment extends the maturity date to October 2030, reduces interest margins by 25 basis points, and appoints Truist Bank as the new administrative agent. Proceeds were partially used to redeem $62 million in outstanding asset-backed notes.

Value
$1B
Counterparty
Truist Bank
Term
through Oct 2030
4:07 PM ET 10-Q
Financial Results Tactile Systems Technology Inc TCMD

Tactile Systems Technology Q3 2026 Results: Net Income $7.16M, Down 12.8% YoY

Tactile Systems Technology reported total revenue of $91.9 million for the quarter ended September 30, 2026, a 7% increase year-over-year, though net income decreased slightly to $7.2 million. The company expanded its portfolio through the acquisition of LymphaTech and an exclusive distribution agreement for the MyoSleeve wearable compression device.

Key figure
Net income $7.16M · -12.8% YoY
4:07 PM ET 8-K
Financial Results Viper Energy, Inc. VNOM

Viper Energy Financial Results

Viper Energy reported third quarter 2026 financial results, highlighted by net income of $300 million and average daily production of 69,076 bo/d. The company also announced the completion of the McElroy Ranch Acquisition for $529 million and declared a quarterly cash dividend of $0.50 per share.

4:07 PM ET 8-K
Financial Results Emergent BioSolutions Inc. EBS

Emergent BioSolutions Financial Results

Emergent BioSolutions reported Q3 2026 total revenues of $110.0 million, a 52% decrease year-over-year, and a net loss of $32.7 million. The results were primarily driven by the company's biodefense and naloxone portfolios as it continues a multi-year strategic transformation and turnaround.

Term
Q3 2026

“Emergent's third-quarter results, which include revenue of $110.0 million inline with our guidance, were primarily driven by our diverse biodefense/medical countermeasures and naloxone portfolio, underscoring the importance of disciplined execution as we advance our multi-year transformation.”

Joe Papa, president and chief executive officer

“We remain focused on our turnaround priorities and strengthening our financial position, which includes improving operating performance, reducing debt, creating long-term shareholder value, continuously demonstrating high standards of quality and compliance in all we do and delivering on our mission to protect and save lives.”

Joe Papa, president and chief executive officer
4:07 PM ET 8-K
Financial Results Sabra Health Care REIT, Inc. SBRA

Sabra Health Care REIT Financial Results

Sabra Health Care REIT reported Q3 2026 net income of $0.11 per diluted share and Normalized AFFO of $0.41 per share. The company updated its full-year 2026 guidance, raising its Normalized AFFO range to $1.600 - $1.610 per share, and highlighted $747.2 million in year-to-date investments with an 8.0% estimated yield.

Term
Q3 2026
4:07 PM ET 8-K
Financial Results Independence Realty Trust, Inc. IRT

Independence Realty Trust Financial Results

Independence Realty Trust reported Q3 2026 financial results with net income of $25.1 million and Core FFO of $0.29 per share. The company highlighted 1.6% same-store NOI growth and provided an update on its pending $8 billion merger with Centerspace, which is expected to close in late 2026. Management noted improving leasing momentum with blended rent growth of 2.8% and steady occupancy of 95.0%.

Counterparty
Centerspace
Term
Q3 2026

“We are pleased with our solid third quarter results, with same-store NOI growth of 1.6% and Core FFO per share of $0.29. Leasing momentum continued to build during the quarter. New lease trade-outs improved 310 basis points year over year, driving blended rent growth of 2.8%, while average occupancy held steady at 95.0% and resident retention remained healthy at 60.5%.”

Scott Schaeffer, Chairman and Chief Executive Officer

“We believe IRT is well positioned for stronger growth in 2027 as concessions burn off, our Wi-Fi program continues to ramp, and supply-demand fundamentals improve. We are also making meaningful progress on integration planning for our pending merger with Centerspace, which we believe will only build on our strength.”

Scott Schaeffer, Chairman and Chief Executive Officer
4:07 PM ET 8-K
Financial Results Gaia, Inc GAIA

Gaia Financial Results

Gaia, Inc. reported third quarter 2026 financial results, showing a 12% revenue decrease to $22.0 million as the company deliberately shifted away from lower ARPU regions and third-party reliance. Despite a net loss of $3.0 million, management highlighted a 20% improvement in member churn and expects to return to positive free cash flow in the fourth quarter.

Term
Q3 2026

“Our third quarter results reflect the successful completion of the reset we announced at the beginning of March—a deliberate move to reduce our revenue reliance on third parties and lower ARPU regions. As part of this shift to prioritize long-term value, we have largely eliminated discounting, with the sole exception of returning members acquired without meaningful marketing spend. We are already seeing traction from these disciplined choices, with member churn rate improving by more than 20% from the first to the third quarter. We remain confident that this focus on the quality of our direct member base is building a stronger, more sustainable foundation.”

Kiersten Medvedich, Chief Executive Officer of Gaia

“Over the last 60 days, our revenue has stabilized at a quarterly run rate around $21.0 million. We have compensated for this lower revenue by effectively reducing expenses, which has allowed our annualized gross profit per employee to continue growing to $827,000. As predicted, we expect to return to positive free cash flow during the fourth quarter, resuming the trend of nine consecutive quarters of positive free cash flow we delivered prior to our March reset.”

Ned Preston, Chief Financial Officer
4:07 PM ET 8-K
Financial Results EverQuote, Inc. EVER

EverQuote Financial Results

EverQuote reported record third quarter 2026 results with revenue growing 25% year-over-year to $218.1 million and net income of $18.2 million. The company exceeded its guidance across all key metrics, driven by strong demand in its automotive and home insurance verticals. Additionally, the board approved a new $50 million share repurchase program.

Term
Q3 2026

“We are generating record results across our key financial metrics as we successfully grow and deepen our relationships with our carrier and agent customers. Carriers continue to maintain strong underwriting profitability and an appetite for growth, and our team is executing seamlessly to meet this demand. As we build on our strong foundation to accelerate new product innovation and development, we believe EverQuote is uniquely positioned to help steward P&C insurance into the agentic AI era.”

Jayme Mendal, Chief Executive Officer of EverQuote

“We reported a record third quarter, delivering revenue growth of 25% year-over-year, highlighting the strength of our market position as a trusted growth partner for our customers. We are focused on accelerating product innovation and unlocking new possibilities to capitalize on the opportunities ahead. Our continued strong growth and execution are enabling us to invest in AI initiatives, while simultaneously generating strong cash flow, maintaining a fortress balance sheet and returning capital to shareholders.”

Joseph Sanborn, Chief Financial Officer and Chief Administrative Officer of EverQuote
4:07 PM ET 8-K
Financial Results Adeia Inc. ADEA

Adeia Financial Results

Adeia Inc. reported Q3 2026 revenue of $80.2 million and GAAP net income of $2.3 million, while announcing the appointment of Dipti Vachani as its new CEO. The company signed eight license agreements during the quarter, including multi-year renewals with Charter and TCL, and updated its full-year 2026 revenue guidance to a range of $360 million to $390 million.

Term
Q3 2026

“I am honored to join Adeia at such an exciting time as AI is driving innovation in both media and semiconductors, and Adeia’s foundational technologies are at the heart of these trends.”

Dipti Vachani, chief executive officer of Adeia

“We remain confident in our ability to achieve the high-end of our revenue guidance range for 2026. However, we felt it prudent to adjust the range to reflect the potential impact to the extent certain of these deals are executed beyond the end of the year.”

Keith Jones, chief financial officer
4:06 PM ET 8-K
Financial Results Backblaze, Inc. BLZE

Backblaze Financial Results

Backblaze reported Q3 2026 financial results with total revenue of $46.7 million, up 26% year-over-year, driven by 47% growth in its B2 Cloud Storage segment. The company significantly improved its bottom line, narrowing its net loss to $2.4 million and achieving an Adjusted EBITDA margin of 33%.

Term
Q3 2026

“Q3 2026 was another strong quarter, with B2 revenue growth accelerating to 47% year over year, up from 28% a year ago, reflecting broad-based momentum across our customer base.”

Gleb Budman, co-founder and CEO of Backblaze
4:06 PM ET 8-K
Capital Raise ISQ Open Infrastructure Co LLC

ISQ Open Infrastructure Co Capital Raise of $29.5M

ISQ Open Infrastructure Company LLC issued and sold unregistered shares across multiple classes for total aggregate net consideration of approximately $29.5 million. The shares were sold to investors for cash and issued to independent directors for services rendered. The company also reported its monthly Transactional Net Asset Value (NAV) per share as of September 30, 2026.

Value
$29.5M
4:06 PM ET 8-K
Financial Results Vertex Pharmaceuticals Inc VRTX

Vertex Pharmaceuticals Financial Results

Vertex Pharmaceuticals reported Q3 2026 revenue of $3.44 billion, a 12% increase year-over-year, driven by strong demand for its cystic fibrosis therapies and new product launches. The company raised its full-year 2026 revenue guidance to a range of $13.15 billion to $13.25 billion. During the quarter, Vertex also completed the $9 billion acquisition of Crinetics Pharmaceuticals and secured a $4.5 billion term loan.

“Vertex delivered excellent third quarter results marked by strong revenue growth across the increasingly diversified portfolio, continued advancement of the R&D pipeline, and the successful close of the Crinetics Pharmaceuticals acquisition.”

Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex

“With the potential povetacicept approval in IgAN coming later this month, we are well positioned to establish nephrology as our fifth commercial franchise and expand the reach of our transformative medicines to even more patients.”

Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex
4:06 PM ET 8-K
Investor Presentation Independent Bank Corp INDB

Independent Bank Investor Presentation

Independent Bank Corp. filed an investor presentation to be used at the KBW 2026 Boston Bank Day on November 3, 2026. The presentation highlights the company's $25.0 billion in total assets and record operating EPS of $1.90 for the third quarter of 2026.

4:06 PM ET 8-K
Financial Results Travere Therapeutics, Inc. TVTX

Travere Therapeutics Financial Results

Travere Therapeutics reported Q3 2026 financial results, highlighted by $200.2 million in FILSPARI net product sales, representing 120% year-over-year growth. The company is advancing its Phase 3 HARMONY study of pegtibatinase with topline results expected in the second half of 2027 and plans to submit an IND for civorebrutinib by year-end.

“Strong execution across our business drove another quarter of significant growth, with FILSPARI net product sales of $200 million for the quarter as we continued to expand our reach in IgAN and FSGS.”

Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics

“As I prepare to transition leadership to Bradley Campbell in December, I have never been more confident in Travere’s future, supported by an exceptional team, an expanding pipeline and a shared commitment to delivering hope to patients.”

Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.